Indefinite Delivery Contract SPE2DR25D9365

The federal contract IDV award is for an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract, valued at $499,999,999, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract has a base period through November 2026 with no set-aside designation, allowing DMS Pharmaceutical Group to leverage its small business status to secure direct federal awards across multiple product categories.

The original solicitation was for the DLA Troop Support Medical Supply Chain's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract, which aims to establish multiple regional Prime Vendor Contracts to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, United States Coast Guard, and US Naval Fleet. The total estimated value for all regions and option periods is $30.3 billion, with awards to be made on a regional basis to at least three different contractors to ensure resiliency and access to vital pharmaceuticals during contingencies or natural disasters.